Involvement of p38 mitogen–activated protein kinase in different stages of thymocyte development
- 1 February 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (3) , 970-976
- https://doi.org/10.1182/blood-2002-03-0744
Abstract
Positive selection of thymocytes during T-cell development is mediated by T-cell receptor (TCR)–activated signals. For different mitogen-activated protein kinases (MAPKs) activated by TCR complex, a selective involvement of extracellular signal–regulated kinase, but not p38 MAPK, in positive selection has been suggested. Using transgenic mice with dominant-negative mutation of both MAP kinase kinase 3 (MMK3) and MKK6, we obtained mice with different extents of inhibition of p38 MAPK activation. Partial inhibition of p38 MAPK impaired CD4−CD8− thymocyte development and T-cell proliferation, but not positive selection. Interference with thymocyte positive selection was observed in mice with effective suppression of p38 MAPK. Our results suggest that, in addition to early thymocyte development, p38 is involved in positive selection.Keywords
This publication has 39 references indexed in Scilit:
- Requirement for p38α in Erythropoietin ExpressionCell, 2000
- Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular DevelopmentMolecular Cell, 2000
- Deficiency of the Stress Kinase P38α Results in Embryonic LethalityThe Journal of Experimental Medicine, 2000
- Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout MiceScience, 1999
- SELECTION OF THE T CELL REPERTOIREAnnual Review of Immunology, 1999
- Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κBThe Journal of Experimental Medicine, 1997
- Positive Selection of ThymocytesAnnual Review of Immunology, 1995
- Regulation of RAG‐1 and CD69 expression in the thymus during positive and negative selectionEuropean Journal of Immunology, 1994
- Activation events during thymic selection.The Journal of Experimental Medicine, 1992
- Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptorNature, 1989